The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACCELERON PHARMA INC | COM | 00434H108 | 31,649 | 1,240,173 | SH | SOLE | 1,240,173 | 0 | 0 | ||
| APOLLO ENDOSURGERY INC | COM | 03767D108 | 17,716 | 1,456,972 | SH | SOLE | 1,456,972 | 0 | 0 | ||
| COLUCID PHARMACEUTICALS INC | COM | 19716T101 | 114,899 | 3,156,563 | SH | SOLE | 3,156,563 | 0 | 0 | ||
| CORVUS PHARMACEUTICALS INC | COM | 221015100 | 46,104 | 3,224,046 | SH | SOLE | 3,224,046 | 0 | 0 | ||
| CRISPR THERAPEUTICS AG | NAMEN AKT | H17182108 | 4,524 | 223,317 | SH | SOLE | 223,317 | 0 | 0 | ||
| DERMIRA INC | COM | 24983L104 | 6,568 | 216,562 | SH | SOLE | 216,562 | 0 | 0 | ||
| FLEXION THERAPEUTICS INC | COM | 33938J106 | 26,585 | 1,397,718 | SH | SOLE | 1,397,718 | 0 | 0 | ||
| HTG MOLECULAR DIAGNOSTICS INC | COM | 40434H104 | 2,868 | 1,280,185 | SH | SOLE | 1,280,185 | 0 | 0 | ||
| INOGEN INC | COM | 45780L104 | 238,408 | 3,549,320 | SH | SOLE | 3,549,320 | 0 | 0 | ||
| INVUITY INC | COM | 46187J205 | 7,581 | 1,318,448 | SH | SOLE | 1,318,448 | 0 | 0 | ||
| IRHYTHM TECHNOLOGIES INC | COM | 450056106 | 60,733 | 2,024,448 | SH | SOLE | 2,024,448 | 0 | 0 | ||
| KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 20,517 | 2,901,927 | SH | SOLE | 2,901,927 | 0 | 0 | ||
| MERUS N V | COM | N5749R100 | 29,774 | 1,410,417 | SH | SOLE | 1,410,417 | 0 | 0 | ||
| NABRIVA THERAPEUTICS AG | COM | 62957M104 | 13,866 | 2,326,544 | SH | SOLE | 2,326,544 | 0 | 0 | ||
| OPKO HEALTH INC | COM | 68375N103 | 2 | 259 | SH | SOLE | 259 | 0 | 0 | ||
| RA PHARMACEUTICALS INC | COM | 74933V108 | 30,859 | 2,031,562 | SH | SOLE | 2,031,562 | 0 | 0 | ||
| REATA PHARMACEUTICALS INC | CL A | 75615P103 | 73,518 | 3,367,763 | SH | SOLE | 3,367,763 | 0 | 0 | ||
| SPECTRANETICS CORP | COM | 84760C107 | 28,889 | 1,179,122 | SH | SOLE | 1,179,122 | 0 | 0 | ||
| VANGUARD INDEX FDS | TOTAL STK MKT | 922908769 | 187,176 | 1,623,100 | SH | SOLE | 1,623,100 | 0 | 0 | ||
| VANGUARD INTL EQUITY INDEX F | FTSE EUROPE ETF | 922042874 | 100,722 | 2,101,000 | SH | SOLE | 2,101,000 | 0 | 0 | ||
| WRIGHT MED GROUP N V | RIGHT 03/01/2019 | N96617126 | 6,101 | 4,622,032 | PRN | SOLE | 0 | 0 | 4,622,032 | ||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 982 | 127,563 | SH | SOLE | 127,563 | 0 | 0 | ||